CRACD and small cell lung carcinoma: CRPR2 mice showed marked increases in tumor burden and number (Fig. 1a-d) and mitotic index of SCLC tumors compared to those of RPR2 mice (Fig. 1e), indicating that Cracd KO accelerates SCLC tumor development in vivo.